Mendelian and complex genetics of susceptibility and resistance to parasitic infections

Seminars in Immunology

Volumn 18, Issue 6, 2006, Pages 411-422

  Campino, Susana ^a   Kwiatkowski, Dominic ^a   Dessein, Alain ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSERM   (France)

Author keywords

Genetics; Leishmaniasis; Malaria; Parasitic infections; Schistosomiasis

Indexed keywords

ENVIRONMENTAL FACTOR; FAMILY; GENE; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HEREDITY; HUMAN; INFECTION RESISTANCE; INFECTION SENSITIVITY; LEISHMANIASIS; LIVER DISEASE; MALARIA; NONHUMAN; PARASITE; PARASITOSIS; REVIEW; SCHISTOSOMIASIS; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEISHMANIASIS; MALARIA; MICE; PARASITIC DISEASES; SCHISTOSOMIASIS;

EID: 33749439167     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2006.07.011     Document Type: Review

References (137)

1. WHO. World Health Organization http://wwwwhoint/en/; 2005.
2. Flint J., Harding R.M., Boyce A.J., and Clegg J.B. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol 11 (1998) 1-51
3. Tishkoff S.A., and Williams S.M. Genetic analysis of African populations: human evolution and complex disease. Nat Rev Genet 3 (2002) 611-621
4. Kwiatkowski D.P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 77 (2005) 171-192
5. Haldane J.B.S. Disease and evolution. Ricerca Sci 19 Suppl. (1949) 3-10
6. Weatherall D.J., and Clegg J.B. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 79 (2001) 704-712
7. Min-Oo G., and Gros P. Erythrocyte variants and the nature of their malaria protective effect. Cell Microbiol 7 (2005) 753-763
8. Allen S., Bennett S., Riley E.M., Rowe P.A., Jakobsen P.H., O'Donnell A., et al. Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in the Gambia. Trans R Soc Trop Med Hyg 86 (1992) 494-498
9. Allison A.C. Protection afforded by sickle-cell trait against subtertian malarial infection. Br Med J 1 (1954) 290-294
10. Hill A.V., Allsopp C.E., Kwiatkowski D., Anstey N.M., Twumasi P., Rowe P.A., et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 352 (1991) 595-600
11. Aidoo M., Terlouw D.J., Kolczak M.S., McElroy P.D., ter Kuile F.O., Kariuki S., et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 359 (2002) 1311-1312
12. Ackerman H., JallowM U.S., Sisay-Joof F., Pinder M., and Kwiatkowski D.P. A comparison of case-control and familybased association methods: the example of sickle-cell and malaria. Ann Hum Genet 69 (2005) 559-565
13. Pasvol G., Weatherall D.J., and Wilson R.J. Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria. Nature 274 (1978) 701-703
14. Ayi K., Turrini F., Piga A., and Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 104 (2004) 3364-3371
15. Rihet P., Flori L., Tall F., Traore A.S., and Fumoux F. Hemoglobin C is associated with reduced Plasmodium falciparum parasitemia and low risk of mild malaria attack. Hum Mol Genet 13 (2004) 1-6
16. Mockenhaupt F.P., Ehrhardt S., Cramer J.P., Otchwemah R.N., Anemana S.D., Goltz K., et al. Hemoglobin C and resistance to severe malaria in Ghanaian children. J Infect Dis 190 (2004) 1006-1009
17. Agarwal A., Guindo A., Cissoko Y., Taylor J.G., Coulibaly D., Kone A., et al. Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Blood 96 (2000) 2358-2363
18. Modiano D., Luoni G., Sirima B.S., Simpore J., Verra F., Konate A., et al. Haemoglobin C protects against clinical plasmodium falciparum malaria. Nature 414 (2001) 305-308
19. Tokumasu F., Fairhurst R.M., Ostera G.R., Brittain N.J., Hwang J., Wellems T.E., et al. Band 3 modifications in Plasmodium falciparum-infected AA and CC erythrocytes assayed by autocorrelation analysis using quantum dots. J Cell Sci 118 (2005) 1091-1098
20. Arie T., Fairhurst R.M., Brittain N.J., Wellems T.E., and Dvorak J.A. Hemoglobin C modulates the surface topography of Plasmodium falciparum-infected erythrocytes. J Struct Biol 150 (2005) 163-169
21. Fairhurst R.M., Baruch D.I., Brittain N.J., Ostera G.R., Wallach J.S., Hoang H.L., et al. Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria. Nature 435 (2005) 1117-1121
22. Chotivanich K., Udomsangpetch R., Pattanapanyasat K., Chierakul W., Simpson J., Looareesuwan S., et al. Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Blood 100 (2002) 1172-1176
23. Mockenhaupt F.P., Ehrhardt S., Gellert S., Otchwemah R.N., Dietz E., Anemana S.D., et al. Alpha(+)-thalassemia protects African children from severe malaria. Blood 104 (2004) 2003-2006
24. Allen S.J., O'Donnell A., Alexander N.D., Alpers M.P., Peto T.E., Clegg J.B., et al. alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 94 (1997) 14736-14741
25. Williams T.N., Wambua S., Uyoga S., Macharia A., Mwacharo J.K., Newton C.R., et al. Both heterozygous and homozygous alpha + thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya. Blood 106 (2005) 368-371
26. Williams T.N., Maitland K., Ganczakowski M., Peto T.E., Clegg J.B., Weatherall D.J., et al. Red blood cell phenotypes in the alpha + thalassaemias from early childhood to maturity. Br J Haematol 95 (1996) 266-272
27. Pattanapanyasat K., Yongvanitchit K., Tongtawe P., Tachavanich K., Wanachiwanawin W., Fucharoen S., et al. Impairment of Plasmodium falciparum growth in thalassemic red blood cells: further evidence by using biotin labeling and flow cytometry. Blood 93 (1999) 3116-3119
28. Williams T.N., Weatherall D.J., and Newbold C.I. The membrane characteristics of Plasmodium falciparum-infected and -uninfected heterozygous alpha(0)thalassaemic erythrocytes. Br J Haematol 118 (2002) 663-670
29. Sabeti P.C., Reich D.E., Higgins J.M., Levine H.Z., Richter D.J., Schaffner S.F., et al. Detecting recent positive selection in the human genome from haplotype structure. Nature 419 (2002) 832-837
30. Ruwende C., Khoo S.C., Snow R.W., Yates S.N., Kwiatkowski D., Gupta S., et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376 (1995) 246-249
31. Cappadoro M., Giribaldi G., O'Brien E., Turrini F., Mannu F., Ulliers D., et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 92 (1998) 2527-2534
32. Cattani J.A., Gibson F.D., Alpers M.P., and Crane G.G. Hereditary ovalocytosis and reduced susceptibility to malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 81 (1987) 705-709
33. Foo L.C., Rekhraj V., Chiang G.L., and Mak J.W. Ovalocytosis protects against severe malaria parasitemia in the Malayan aborigines. Am J Trop Med Hyg 47 (1992) 271-275
34. Genton B., al-Yaman F., Mgone C.S., Alexander N., Paniu M.M., Alpers M.P., et al. Ovalocytosis and cerebral malaria. Nature 378 (1995) 564-565
35. Allen S.J., O'Donnell A., Alexander N.D., Mgone C.S., Peto T.E., Clegg J.B., et al. Prevention of cerebral malaria in children in Papua New Guinea by Southeast Asian ovalocytosis band 3. Am J Trop Med Hyg 60 (1999) 1056-1060
36. Miller L.H., Mason S.J., Clyde D.F., and McGinniss M.H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295 (1976) 302-304
37. Tournamille C., Colin Y., Cartron J.P., and Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 10 (1995) 224-228
38. Hadley T.J., Klotz F.W., Pasvol G., Haynes J.D., McGinniss M.H., Okubo Y., et al. Falciparum malaria parasites invade erythrocytes that lack glycophorin A and B (MkMk). Strain differences indicate receptor heterogeneity and two pathways for invasion. J Clin Invest 80 (1987) 1190-1193
39. Facer C.A. Merozoites of P. falciparum require glycophorin for invasion into red cells. Bull Soc Pathol Exot Filiales 76 (1983) 463-469
40. Maier A.G., Duraisingh M.T., Reeder J.C., Patel S.S., Kazura J.W., Zimmerman P.A., et al. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med 9 (2003) 87-92
41. Hill A.V., Elvin J., Willis A.C., Aidoo M., Allsopp C.E., Gotch F.M., et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360 (1992) 434-439
42. McGuire W., Hill A.V., Allsopp C.E., Greenwood B.M., and Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371 (1994) 508-510
43. Meyer C.G., May J., Luty A.J., Lell B., and Kremsner P.G. TNFalpha-308A associated with shorter intervals of Plasmodium falciparum reinfections. Tissue Antigens 59 (2002) 287-292
44. Aidoo M., McElroy P.D., Kolczak M.S., Terlouw D.J., ter Kuile F.O., Nahlen B., et al. Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX. Genet Epidemiol 21 (2001) 201-211
45. McGuire W., Knight J.C., Hill A.V., Allsopp C.E., Greenwood B.M., and Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 179 (1999) 287-290
46. Knight J.C., Udalova I., Hill A.V., Greenwood B.M., Peshu N., Marsh K., et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 22 (1999) 145-150
47. Flori L., Delahaye N.F., Iraqi F.A., Hernandez-Valladares M., Fumoux F., and Rihet P. TNF as a malaria candidate gene: polymorphism-screening and family-based association analysis of mild malaria attack and parasitemia in Burkina Faso. Genes Immun 6 (2005) 472-480
48. Ackerman H.C., Ribas G., Jallow M., Mott R., Neville M., Sisay-Joof F., et al. Complex haplotypic structure of the central MHC region flanking TNF in a West African population. Genes Immun 4 (2003) 476-486
49. Abel L., Cot M., Mulder L., Carnevale P., and Feingold J. Segregation analysis detects a major gene controlling blood infection levels in human malaria. Am J Hum Genet 50 (1992) 1308-1317
50. Garcia A., Cot M., Chippaux J.P., Ranque S., Feingold J., Demenais F., et al. Genetic control of blood infection levels in human malaria: evidence for a complex genetic model. Am J Trop Med Hyg 58 (1998) 480-488
51. Rihet P., Traore Y., Abel L., Aucan C., Traore-Leroux T., and Fumoux F. Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am J Hum Genet 63 (1998) 498-505
52. Garcia A., Marquet S., Bucheton B., Hillaire D., Cot M., Fievet N., et al. Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am J Trop Med Hyg 58 (1998) 705-709
53. Flori L., Kumulungui B., Aucan C., Esnault C., Traore A.S., Fumoux F., et al. Linkage and association between Plasmodium falciparum blood infection levels and chromosome 5q31-q33. Genes Immun 4 (2003) 265-268
54. Marquet S., Abel L., Hillaire D., Dessein H., Kalil J., Feingold J., et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 14 (1996) 181-184
55. Luoni G., Verra F., Arca B., Sirima B.S., Troye-Blomberg M., Coluzzi M., et al. Antimalarial antibody levels and IL4 polymorphism in the Fulani of West Africa. Genes Immun 2 (2001) 411-414
56. Modiano D., Petrarca V., Sirima B.S., Luoni G., Nebie I., Diallo D.A., et al. Different response to Plasmodium falciparum in west African sympatric ethnic groups: possible implications for malaria control strategies. Parassitologia 41 (1999) 193-197
57. Modiano D., Chiucchiuini A., Petrarca V., Sirima B.S., Luoni G., Perlmann H., et al. Humoral response to Plasmodium falciparum Pf155/ring-infected erythrocyte surface antigen and Pf332 in three sympatric ethnic groups of Burkina Faso. Am J Trop Med Hyg 58 (1998) 220-224
58. Modiano D., Petrarca V., Sirima B.S., Nebie I., Diallo D., Esposito F., et al. Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups. Proc Natl Acad Sci USA 93 (1996) 13206-13211
59. Dolo A., Modiano D., Maiga B., Daou M., Dolo G., Guindo H., et al. Difference in susceptibility to malaria between two sympatric ethnic groups in Mali. Am J Trop Med Hyg 72 (2005) 243-248
60. Clark I.A., and Rockett K.A. Nitric oxide and parasitic disease. Adv Parasitol 37 (1996) 1-56
61. Koch O., Rockett K., Jallow M., Pinder M., Sisay-Joof F., and Kwiatkowski D. Investigation of malaria susceptibility determinants in the IFNG/IL26/IL22 genomic region. Genes Immun 6 (2005) 312-318
62. Cabantous S., Poudiougou B., Traore A., Keita M., Cisse M.B., Doumbo O., et al. Evidence that interferon-gamma plays a protective role during cerebral malaria. J Infect Dis 192 (2005) 854-860
63. Taylor T.E., Fu W.J., Carr R.A., Whitten R.O., Mueller J.S., Fosiko N.G., et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 10 (2004) 143-145
64. Roberts D.J., Craig A.G., Berendt A.R., Pinches R., Nash G., Marsh K., et al. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357 (1992) 689-692
65. Kyes S., Horrocks P., and Newbold C. Antigenic variation at the infected red cell surface in malaria. Annu Rev Microbiol 55 (2001) 673-707
66. Fernandez-Reyes D., Craig A.G., Kyes S.A., Peshu N., Snow R.W., Berendt A.R., et al. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 6 (1997) 1357-1360
67. Kun J.F., Klabunde J., Lell B., Luckner D., Alpers M., May J., et al. Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambarene, Gabon. Am J Trop Med Hyg 61 (1999) 776-779
68. Bellamy R., Kwiatkowski D., and Hill A.V. Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans R Soc Trop Med Hyg 92 (1998) 312-316
69. Urban B.C., Ferguson D.J., Pain A., Willcox N., Plebanski M., Austyn J.M., et al. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400 (1999) 73-77
70. Urban B.C., Willcox N., and Roberts D.J. A role for CD36 in the regulation of dendritic cell function. Proc Natl Acad Sci USA 98 (2001) 8750-8755
71. Aitman T.J., Cooper L.D., Norsworthy P.J., Wahid F.N., Gray J.K., Curtis B.R., et al. Malaria susceptibility and CD36 mutation. Nature 405 (2000) 1015-1016
72. Omi K., Ohashi J., Patarapotikul J., Hananantachai H., Naka I., Looareesuwan S., et al. CD36 polymorphism is associated with protection from cerebral malaria. Am J Hum Genet 72 (2003) 364-374
73. Pain A., Urban B.C., Kai O., Casals-Pascual C., Shafi J., Marsh K., et al. A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 357 (2001) 1502-1503
74. Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Peters W, Killick-Kendrick R, editors. The leishmaniases in biology and medicine, vol. 1. London: Academic Press; 1987. p. 1-120.
75. Shaw M.A., Davies C.R., Llanos-Cuentas E.A., and Collins A. Human genetic susceptibility and infection with Leishmania peruviana. Am J Hum Genet 57 (1995) 1159-1168
76. Alcais A., Abel L., David C., Torrez M.E., Flandre P., and Dedet J.P. Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population. Am J Hum Genet 61 (1997) 968-979
77. Barbier D., Demenais F., Lefait J.F., David B., Blanc M., Hors J., et al. Susceptibility to human cutaneous leishmaniasis and HLA, Gm, Km markers. Tissue Antigens 30 (1987) 63-67
78. Lara M.L., Layrisse Z., Scorza J.V., Garcia E., Stoikow Z., Granados J., et al. Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela. Hum Immunol 30 (1991) 129-135
79. Olivo-Diaz A., Debaz H., Alaez C., Islas V.J., Perez-Perez H., Hobart O., et al. Role of HLA class II alleles in susceptibility to and protection from localized cutaneous leishmaniasis. Hum Immunol 65 (2004) 255-261
80. Petzl-Erler M.L., Belich M.P., and Queiroz-Telles F. Association of mucosal leishmaniasis with HLA. Hum Immunol 32 (1991) 254-260
81. Cabrera M., Shaw M.A., Sharples C., Williams H., Castes M., Convit J., et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182 (1995) 1259-1264
82. Ibrahim M.E., Lambson B., Yousif A.O., Deifalla N.S., Alnaiem D.A., Ismail A., et al. El Hassan AM. Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am J Trop Med Hyg 61 (1999) 941-944
83. Bucheton B., Kheir M.M., El-Safi S.H., Hammad A., Mergani A., Mary C., et al. The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes Infect 4 (2002) 1449-1457
84. Peacock C.S., Collins A., Shaw M.A., Silveira F., Costa J., Coste C.H., et al. Genetic epidemiology of visceral leishmaniasis in northeastern Brazil. Genet Epidemiol 20 (2001) 383-396
85. El-Safi S.H., Bucheton B., Kheir M.M., Musa H.A., M EL-O, Hammad A., and Dessein A. Epidemiology of visceral leishmaniasis in Atbara River area, eastern Sudan: the outbreak of Barbar El Fugara village (1996-1997). Microbes Infect 4 (2002) 1439-1447
86. Bucheton B., Abel L., Kheir M.M., Mirgani A., El-Safi S.H., Chevillard C., et al. Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immun 4 (2003) 104-109
87. Mohamed H.S., Ibrahim M.E., Miller E.N., White J.K., Cordell H.J., Howson J.M., et al. SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. Eur J Hum Genet 12 (2004) 66-74
88. Bucheton B., Abel L., El-Safi S., Kheir M.M., Pavek S., Lemainque A., et al. A major susceptibility locus on chromosome 22q12 plays a critical role in the control of Kala-azar. Am J Hum Genet 73 (2003) 1052-1060
89. Mohamed H.S., Ibrahim M.E., Miller E.N., Peacock C.S., Khalil E.A., Cordell H.J., et al. Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1. Genes Immun 4 (2003) 351-355
90. Peacock C.S., Sanjeevi C.B., Shaw M.A., Collins A., Campbell R.D., March R., et al. Genetic analysis of multicase families of visceral leishmaniasis in northeastern Brazil: no major role for class II or class III regions of HLA. Genes Immun 3 (2002) 350-358
91. Meddeb-Garnaoui A., Gritli S., Garbouj S., Ben Fadhel M., El Kares R., Mansour L., et al. Association analysis of HLA-class II and class III gene polymorphisms in the susceptibility to mediterranean visceral leishmaniasis. Hum Immunol 62 (2001) 509-517
92. Singh N., Sundar S., Williams F., Curran M.D., Rastogi A., Agrawal S., et al. Molecular typing of HLA class I and class II antigens in Indian Kala-azar patients. Trop Med Int Health 2 (1997) 468-471
93. Dessein A.J., Couissinier P., Demeure C., Rihet P., Kohlstaedt S., Carneiro-Carvalho D., et al. Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni. Immunol Invest 21 (1992) 423-453
94. Abel L., Demenais F., Prata A., Souza A.E., and Dessein A. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 48 (1991) 959-970
95. Marquet S., Abel L., Hillaire D., and Dessein A. Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Eur J Hum Genet 7 (1999) 88-97
96. Muller-Myhsok B., Stelma F.F., Guisse-Sow F., Muntau B., Thye T., Burchard G.D., et al. Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni. Am J Hum Genet 61 (1997) 452-454
97. Hagan P., Blumenthal U.J., Dunn D., Simpson A.J., and Wilkins H.A. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349 (1991) 243-245
98. Rihet P., Demeure C.E., Bourgois A., Prata A., and Dessein A.J. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 21 (1991) 2679-2686
99. Rihet P., Demeure C.E., Dessein A.J., and Bourgois A. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area. Eur J Immunol 22 (1992) 2063-2070
100. Rodrigues Jr. V., Piper K., Couissinier-Paris P., Bacelar O., Dessein H., and Dessein A.J. Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes. Infect Immun 67 (1999) 4689-4692
101. Kouriba B., Chevillard C., Bream J.H., Argiro L., Dessein H., Arnaud V., et al. Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections. J Immunol 174 (2005) 6274-6281
102. van der Pouw Kraan T.C., van Veen A., Boeije L.C., van Tuyl S.A., de Groot E.R., Stapel S.O., et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1 (1999) 61-65
103. Liu X., Beaty T.H., Deindl P., Huang S.K., Lau S., Sommerfeld C., et al. Associations between total serum IgE levels and the 6 potentially functional variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. J Allergy Clin Immunol 112 (2003) 382-388
104. Liu X., Beaty T.H., Deindl P., Huang S.K., Lau S., Sommerfeld C., et al. Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. J Allergy Clin Immunol 113 (2004) 489-495
105. Dessein A., Kouriba B., Eboumbou C., Dessein H., Argiro L., Marquet S., et al. Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis. Immunol Rev 201 (2004) 180-190
106. Mohamed-Ali Q., Elwali N.E., Abdelhameed A.A., Mergani A., Rahoud S., Elagib K.E., et al. Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J Infect Dis 180 (1999) 1298-1306
107. Ellis M.K., Li Y., Rong Z., Chen H., and McManus D.P. Familial aggregation of human infection with Schistosoma japonicum in the Poyang Lake region, China. Int J Parasitol 36 (2006) 71-77
108. Seto E.Y., Zhong B., Kouch J., Hubbard A., and Spear R.C. Genetic and household risk factors for Schistosoma Japonicum infection in the presence of larger scale environmental differences in the mountainous transmission areas of China. Am J Trop Med Hyg 73 (2005) 1145-1150
109. Dessein A.J., Hillaire D., Elwali N.E., Marquet S., Mohamed-Ali Q., Mirghani A., et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 65 (1999) 709-721
110. Blanton R.E., Salam E.A., Ehsan A., King C.H., and Goddard K.A. Schistosomal hepatic fibrosis and the interferon gamma receptor: a linkage analysis using single-nucleotide polymorphic markers. Eur J Hum Genet 13 (2005) 660-668
111. Gressner A.M. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol 22 (1995) 28-36
112. Duncan M.R., and Berman B. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 162 (1985) 516-527
113. Mallat A., Preaux A.M., Blazejewski S., Rosenbaum J., Dhumeaux D., and Mavier P. Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 21 (1995) 1003-1010
114. Henri S., Chevillard C., Mergani A., Paris P., Gaudart J., Camilla C., et al. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol 169 (2002) 929-936
115. Chevillard C., Moukoko C.E., Elwali N.E., Bream J.H., Kouriba B., Argiro L., et al. IFN-gamma polymorphisms (IFN-gamma + 2109 and IFN-gamma + 3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol 171 (2003) 5596-5601
116. Chevillard C., Henri S., Stefani F., Parzy D., and Dessein A. Two new polymorphisms in the human interferon gamma (IFN-gamma) promoter. Eur J Immunogenet 29 (2002) 53-56
117. Hirayama K. Genetic factors associated with development of cerebral malaria and fibrotic schistosomiasis. Kor J Parasitol 40 (2002) 165-172
118. Abaza H., Asser L., el Sawy M., Wasfy S., Montaser L., Hagras M., et al. HLA antigens in schistosomal hepatic fibrosis patients with haematemesis. Tissue Antigens 26 (1985) 307-309
119. Abdel-Salam E., Abdel Khalik A., Abdel-Meguid A., Barakat W., and Mahmoud A.A. Association of HLA class I antigens (A1, B5, B8 and CW2) with disease manifestations and infection in human schistosomiasis mansoni in Egypt. Tissue Antigens 27 (1986) 142-146
120. Cabello P.H., Krieger H., Lopes J.D., and Sant'Ana E.J. On the association between HLA-A1 and B5 and clinical forms of schistosomiasis mansoni. Mem Inst Oswaldo Cruz 86 (1991) 37-40
121. Salam E.A., Ishaac S., and Mahmoud A.A. Histocompatibilty-linked susceptibility for hepatospleenomegaly in human schistosomiasis mansoni. J Immunol 123 (1979) 1829-1831
122. Secor W.E., del Corral H., dos Reis M.G., Ramos E.A., Zimon A.E., Matos E.P., et al. Association of hepatosplenic schistosomiasis with HLA-DQB1*0201. J Infect Dis 174 (1996) 1131-1135
123. Waine G.J., Ross A.G., Williams G.M., Sleigh A.C., and McManus D.P. HLA class II antigens are associated with resistance or susceptibility to hepatosplenic disease in a Chinese population infected with Schistosoma japonicum. Int J Parasitol 28 (1998) 537-542
124. McManus D.P., Ross A.G., Williams G.M., Sleigh A.C., Wiest P., Erlich H., et al. HLA class II antigens positively and negatively associated with hepatosplenic schistosomiasis in a Chinese population. Int J Parasitol 31 (2001) 674-680
125. Hirayama K., Chen H., Kikuchi M., Yin T., Gu X., Liu J., et al. HLA-DR-DQ alleles and HLA-DP alleles are independently associated with susceptibility to different stages of post-schistosomal hepatic fibrosis in the Chinese population. Tissue Antigens 53 (1999) 269-274
126. Moukoko C.E., El Wali N., Saeed O.K., Mohamed-Ali Q., Gaudart J., Dessein A.J., et al. No evidence for a major effect of tumor necrosis factor alpha gene polymorphisms in periportal fibrosis caused by Schistosoma mansoni infection. Infect Immun 71 (2003) 5456-5460
127. Chan S.H., Dissanayake S., Mak J.W., Ismail M.M., Wee G.B., Srinivasan N., et al. HLA and filariasis in Sri Lankans and Indians. Southeast Asian J Trop Med Public Health 15 (1984) 281-286
128. Yazdanbakhsh M., Sartono E., Kruize Y.C., Kurniawan A., Partono F., Maizels R.M., et al. HLA and elephantiasis in lymphatic filariasis. Hum Immunol 44 (1995) 58-61
129. Meyer C.G., Gallin M., Erttmann K.D., Brattig N., Schnittger L., Gelhaus A., et al. HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. Proc Natl Acad Sci USA 91 (1994) 7515-7519
130. Murdoch M.E., Payton A., Abiose A., Thomson W., Panicker V.K., Dyer P.A., et al. HLA-DQ alleles associate with cutaneous features of onchocerciasis. The Kaduna-London-Manchester Collaboration for Research on Onchocerciasis. Hum Immunol 55 (1997) 46-52
131. Donfack J., Ngu J.L., Lando G., Zimmerman P.A., Nutman J., and Same-Ekobo A. Variations under genetic control of onchocerca infection as a function of clinical profile in the endemic center of Cameroon. Bull Soc Pathol Exot 92 (1999) 85-90
132. Nieto A., Beraun Y., Collado M.D., Caballero A., Alonso A., Gonzalez A., et al. HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection. Tissue Antigens 55 (2000) 195-198
133. Fernandez-Mestre M.T., Layrisse Z., Montagnani S., Acquatella H., Catalioti F., Matos M., et al. Influence of the HLA class II polymorphism in chronic Chagas' disease. Parasite Immunol 20 (1998) 197-203
134. Deghaide N.H., Dantas R.O., and Donadi E.A. HLA class I and II profiles of patients presenting with Chagas' disease. Dig Dis Sci 43 (1998) 246-252
135. Courtin D., Argiro L., Jamonneau V., N'Dri L., N'Guessan P., Abel L., et al. Interest of tumor necrosis factor-alpha-308 G/A and interleukin-10-592 C/A polymorphisms in human African trypanosomiasis. Infect Genet Evol (2005)
136. Williams-Blangero S., VandeBerg J.L., Subedi J., Aivaliotis M.J., Rai D.R., Upadhayay R.P., et al. Genes on chromosomes 1 and 13 have significant effects on Ascaris infection. Proc Natl Acad Sci USA 99 (2002) 5533-5538
137. Peisong G., Yamasaki A., Mao X.Q., Enomoto T., Feng Z., Gloria-Bottini F., et al. An asthma-associated genetic variant of STAT6 predicts low burden of ascaris worm infestation. Genes Immun 5 (2004) 58-62